Association of Alk1 and Endoglin Polymorphisms with Cardiovascular Damage

Abstract Cardiovascular diseases are associated to risk factors as obesity, hypertension and diabetes. The transforming growth factor-β1 receptors ALK1 and endoglin regulate blood pressure and vascular homeostasis. However, no studies relate the association of ALK1 and endoglin polymorphisms with ca...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mercedes Garzon-Martinez, Nuria Perretta-Tejedor, Luis Garcia-Ortiz, Manuel A. Gomez-Marcos, Rogelio Gonzalez-Sarmiento, Francisco J. Lopez-Hernandez, Carlos Martinez-Salgado
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2020
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/245dbcaed107499b87ae2429c313079e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:245dbcaed107499b87ae2429c313079e
record_format	dspace
spelling	oai:doaj.org-article:245dbcaed107499b87ae2429c313079e2021-12-02T17:52:33ZAssociation of Alk1 and Endoglin Polymorphisms with Cardiovascular Damage10.1038/s41598-020-66238-92045-2322https://doaj.org/article/245dbcaed107499b87ae2429c313079e2020-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-66238-9https://doaj.org/toc/2045-2322Abstract Cardiovascular diseases are associated to risk factors as obesity, hypertension and diabetes. The transforming growth factor-β1 receptors ALK1 and endoglin regulate blood pressure and vascular homeostasis. However, no studies relate the association of ALK1 and endoglin polymorphisms with cardiovascular risk factors. We analysed the predictive value of the ALK1 and endoglin polymorphisms on cardiovascular target organ damage in hypertensive and diabetic patients in 379 subjects with or without hypertension and diabetes in a Primary Care setting. The ALK1 rs2071219 polymorphism (AA genotype) is associated with a lower presence of diabetic retinopathy and with the absence of altered basal glycaemia. Being carrier of the ALK1 rs3847859 polymorphism (G allele) is associated with lower basal heart rate and with higher LDL-cholesterol levels. The endoglin rs3739817 polymorphism (AA genotype) is associated with higher levels of LDL-cholesterol, and being carrier of the endoglin rs10987759 polymorphism (C allele) is associated with higher haemoglobin levels and with an increased heart rate. Summarizing, several ALK1 and endoglin gene polymorphisms increase the risk of cardiovascular events. The analysis of these polymorphisms in populations at risk, in combination with the determination of other parameters and biomarkers, could implement the diagnosis and prognosis of susceptibility to cardiovascular damage.Mercedes Garzon-MartinezNuria Perretta-TejedorLuis Garcia-OrtizManuel A. Gomez-MarcosRogelio Gonzalez-SarmientoFrancisco J. Lopez-HernandezCarlos Martinez-SalgadoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Mercedes Garzon-Martinez Nuria Perretta-Tejedor Luis Garcia-Ortiz Manuel A. Gomez-Marcos Rogelio Gonzalez-Sarmiento Francisco J. Lopez-Hernandez Carlos Martinez-Salgado Association of Alk1 and Endoglin Polymorphisms with Cardiovascular Damage
description	Abstract Cardiovascular diseases are associated to risk factors as obesity, hypertension and diabetes. The transforming growth factor-β1 receptors ALK1 and endoglin regulate blood pressure and vascular homeostasis. However, no studies relate the association of ALK1 and endoglin polymorphisms with cardiovascular risk factors. We analysed the predictive value of the ALK1 and endoglin polymorphisms on cardiovascular target organ damage in hypertensive and diabetic patients in 379 subjects with or without hypertension and diabetes in a Primary Care setting. The ALK1 rs2071219 polymorphism (AA genotype) is associated with a lower presence of diabetic retinopathy and with the absence of altered basal glycaemia. Being carrier of the ALK1 rs3847859 polymorphism (G allele) is associated with lower basal heart rate and with higher LDL-cholesterol levels. The endoglin rs3739817 polymorphism (AA genotype) is associated with higher levels of LDL-cholesterol, and being carrier of the endoglin rs10987759 polymorphism (C allele) is associated with higher haemoglobin levels and with an increased heart rate. Summarizing, several ALK1 and endoglin gene polymorphisms increase the risk of cardiovascular events. The analysis of these polymorphisms in populations at risk, in combination with the determination of other parameters and biomarkers, could implement the diagnosis and prognosis of susceptibility to cardiovascular damage.
format	article
author	Mercedes Garzon-Martinez Nuria Perretta-Tejedor Luis Garcia-Ortiz Manuel A. Gomez-Marcos Rogelio Gonzalez-Sarmiento Francisco J. Lopez-Hernandez Carlos Martinez-Salgado
author_facet	Mercedes Garzon-Martinez Nuria Perretta-Tejedor Luis Garcia-Ortiz Manuel A. Gomez-Marcos Rogelio Gonzalez-Sarmiento Francisco J. Lopez-Hernandez Carlos Martinez-Salgado
author_sort	Mercedes Garzon-Martinez
title	Association of Alk1 and Endoglin Polymorphisms with Cardiovascular Damage
title_short	Association of Alk1 and Endoglin Polymorphisms with Cardiovascular Damage
title_full	Association of Alk1 and Endoglin Polymorphisms with Cardiovascular Damage
title_fullStr	Association of Alk1 and Endoglin Polymorphisms with Cardiovascular Damage
title_full_unstemmed	Association of Alk1 and Endoglin Polymorphisms with Cardiovascular Damage
title_sort	association of alk1 and endoglin polymorphisms with cardiovascular damage
publisher	Nature Portfolio
publishDate	2020
url	https://doaj.org/article/245dbcaed107499b87ae2429c313079e
work_keys_str_mv	AT mercedesgarzonmartinez associationofalk1andendoglinpolymorphismswithcardiovasculardamage AT nuriaperrettatejedor associationofalk1andendoglinpolymorphismswithcardiovasculardamage AT luisgarciaortiz associationofalk1andendoglinpolymorphismswithcardiovasculardamage AT manuelagomezmarcos associationofalk1andendoglinpolymorphismswithcardiovasculardamage AT rogeliogonzalezsarmiento associationofalk1andendoglinpolymorphismswithcardiovasculardamage AT franciscojlopezhernandez associationofalk1andendoglinpolymorphismswithcardiovasculardamage AT carlosmartinezsalgado associationofalk1andendoglinpolymorphismswithcardiovasculardamage
_version_	1718379156566179840

Association of Alk1 and Endoglin Polymorphisms with Cardiovascular Damage

Ejemplares similares